Episurf Medical
0,139 SEK +0,58%1 investor følger denne virksomhed
Episurf Medical is a medical technology company. The company conducts research and development of products used for the treatment of cartilage damage. Episurf's primary focus is on the recovery of knee joints, but the company's implants can also be applied to other joints. Episurf Medical is in the preclinical verification phase and is headquartered in Stockholm.
Omsætning
10,3 mio.
EBIT %
-938,83 %
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
NASDAQ Stockholm
EPIS B
Daglig lav / høj pris
0,136 / 0,144
SEK
Markedsværdi
90,56 mio. SEK
Aktieomsætning
82,53 t SEK
Volumen
586 t
Seneste videoer
Finanskalender
Årsrapport
05.02.2025
Generalforsamling
03.04.2025
Delårsrapport
25.04.2025
Delårsrapport
11.07.2025
Delårsrapport
24.10.2025
Større aktionærerKilde: Millistream Market Data AB
Ejer | Kapital | Stemmer |
---|---|---|
Health Runner | 10,7 % | 10,7 % |
Six Sis AG, W8IMY | 5,7 % | 5,7 % |
Fjärde AP-Fonden | 5,5 % | 5,5 % |
Nordnet Pensionsförsäkring AB | 4,5 % | 4,5 % |
Försäkringsaktiebolaget Avanza Pension | 4,3 % | 4,3 % |
SEB Life International Assurance | 3,0 % | 3,0 % |
Ålandsbanken Abp (Finland), svensk filial | 2,8 % | 2,8 % |
Tellus Fonder AB | 2,0 % | 2,0 % |
ViserAlle indholdstyper
Episurf: Interim Report 1 January - 30 September 2024
Members of the Nomination Committee for Episurf Medical's Annual General Meeting in 2025
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools